Insights
UK patients to access first-ever export of Australian medicinal cannabis oil
An Australian first. Read more on our export of medicinal cannabis for UK patients.
Apr 2020
24 Apr 2020
Australian medical cannabis producer Little Green Pharma recently became the first, and currently only, in its native country to bring locally-grown medical-grade products to market.
It is now plotting international growth, having recently exported medicinal cannabis products for patient use in the UK.
The firm was initially established to help a family access cannabis whose child was suffering up to 70 seizures a day, after the substance was legalised in Australia in late 2016.
The company quickly built a reputation and market presence through its first mover advantage and its vision to develop a precision dosing methodology, which effectively optimises the cannabis needed to be consumed to achieve the same results.
It recently raised $10m to fuel its expansion after listing on the Australian Securities Exchange (ASX), Little Green Pharma – the first business to ever export Australian medicinal cannabis – is now looking at global opportunities.
Earlier this month it entered the UK market after securing an import and distribution partnership with Astral Health, a subsidiary of the LYPHE Group.
Read the full article here: https://www.cannabishealthnews.co.uk/2020/04/24/big-plans-for-little-green-pharma/
Insights
An Australian first. Read more on our export of medicinal cannabis for UK patients.
Apr 2020
Insights
Little Green Pharma raised the maximum subscription amount of $10 million in an oversubscribed IPO.
Feb 2020
Regulatory News
Mar 2021